New report published by Global Info Research which offers insights on the global Mesenchymal Stem Cells market.
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
Click to view the full report TOC, figure and tables:
Global Mesenchymal Stem Cells Market: Forecast by Type / Application / Region
Market Segment by Manufacturers covers: Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences and Axol Bioscience.
Market Segment by Type covers: Human MSC, Mouse MSC, Rat MSC and Other.
Market Segment by Applications be divided into: Research Institute, Hospital and Others.
The global average gross margin of Mesenchymal Stem Cells is in the fluctuation trend, from 70% in 2012 to 67% in 2016. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of Mesenchymal Stem Cells includes Human, Mouse, Rat. The proportion of Human in 2015 is about 39%, and the proportion of Mouse in 2016 is about 31%.
Mesenchymal Stem Cells are widely sold in Research Institutes and Hospitals segment. The most proportion of Mesenchymal Stem Cells are sold in Research Institutes and the market share in 2016 is about 76%, but the Hospitals have upstream trend.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41% in 2016. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31% in 2016.Market competition is intense between the region’s research institutes and hospital. In the future, the hospital will have larger market share.
Ask for Discount on Research Report and Request Sample Copy of Report@
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States Mesenchymal Stem Cells Market 2018 Forecast to 2023
Europe Mesenchymal Stem Cells Market 2018 Forecast to 2023
North America Mesenchymal Stem Cells Market 2018 Forecast to 2023
Asia-Pacific Mesenchymal Stem Cells Market 2018 Forecast to 2023
China Mesenchymal Stem Cells Market 2018 Forecast to 2023
EMEA Mesenchymal Stem Cells Market 2018 Forecast to 2023
Global Mesenchymal Stem Cells Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com